0001209191-17-059249.txt : 20171103 0001209191-17-059249.hdr.sgml : 20171103 20171103171230 ACCESSION NUMBER: 0001209191-17-059249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171102 FILED AS OF DATE: 20171103 DATE AS OF CHANGE: 20171103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hagen Elisabeth CENTRAL INDEX KEY: 0001721211 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 171177421 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-02 0 0001006028 PURE BIOSCIENCE, INC. PURE 0001721211 Hagen Elisabeth 1725 GILLESPIE WAY EL CAJON CA 92020 1 0 0 0 Common Stock 2017-11-02 4 A 0 150000 0.00 A 150000 D Stock Option (Right to Buy) 1.105 2017-11-02 4 A 0 200000 0.00 A 2027-11-02 Common Stock 200000 200000 D Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. /s/ Elisabeth Hagen 2017-11-03